IGM BIOSCIENCES INC's ticker is IGMS and the CUSIP is 449585108. A total of 81 filers reported holding IGM BIOSCIENCES INC in Q2 2023. The put-call ratio across all filers is 0.80 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $24,199 | +4.2% | 2,898 | +15.2% | 0.00% | 0.0% |
| Q2 2023 | $23,223 | +27546.4% | 2,516 | -58.9% | 0.00% | -66.7% |
| Q1 2023 | $84 | +740.0% | 6,122 | +923.7% | 0.00% | – |
| Q4 2022 | $10 | -100.0% | 598 | -70.4% | 0.00% | -100.0% |
| Q3 2022 | $46,000 | -47.1% | 2,019 | -58.4% | 0.00% | -50.0% |
| Q2 2022 | $87,000 | -69.9% | 4,852 | -55.2% | 0.00% | -33.3% |
| Q1 2022 | $289,000 | +373.8% | 10,823 | +418.6% | 0.00% | +200.0% |
| Q4 2021 | $61,000 | +17.3% | 2,087 | +165.5% | 0.00% | 0.0% |
| Q3 2021 | $52,000 | -26.8% | 786 | -7.7% | 0.00% | -50.0% |
| Q2 2021 | $71,000 | -42.3% | 852 | -46.8% | 0.00% | 0.0% |
| Q1 2021 | $123,000 | +46.4% | 1,603 | +68.6% | 0.00% | -33.3% |
| Q4 2020 | $84,000 | -8.7% | 951 | -24.2% | 0.00% | +200.0% |
| Q3 2020 | $92,000 | -57.4% | 1,254 | -57.5% | 0.00% | -88.9% |
| Q2 2020 | $216,000 | +1863.6% | 2,954 | +1362.4% | 0.01% | +800.0% |
| Q1 2020 | $11,000 | – | 202 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Redmile Group, LLC | 3,334,355 | $75,823,000 | 2.94% |
| Artal Group S.A. | 2,450,000 | $55,713,000 | 2.38% |
| Samsara BioCapital, LLC | 154,664 | $3,517,000 | 0.82% |
| Eagle Bay Advisors LLC | 41,635 | $947,000 | 0.58% |
| Baker Brothers Advisors | 3,156,102 | $71,770,000 | 0.47% |
| Bruce & Co., Inc. | 55,000 | $1,250,000 | 0.34% |
| Corton Capital Inc. | 9,999 | $227,000 | 0.28% |
| Delphia (USA) Inc. | 10,185 | $232,000 | 0.26% |
| Alkeon Capital Management | 961,613 | $21,867,000 | 0.07% |
| Virtus ETF Advisers LLC | 7,319 | $166,000 | 0.07% |